• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ear Nose Throat J . Association Between Severity of COVID-19 Respiratory Disease and Risk of Obstructive Sleep Apnea

tetano

Editor, Senior Moderator
Ear Nose Throat J


. 2021 Jul 28;1455613211029783.
doi: 10.1177/01455613211029783. Online ahead of print.
Association Between Severity of COVID-19 Respiratory Disease and Risk of Obstructive Sleep Apnea


Giannicola Iannella[SUP] 1 [/SUP], Claudio Vicini[SUP] 1 2 [/SUP], Jerome R Lechien[SUP] 3 [/SUP], Claudia Ravaglia[SUP] 4 [/SUP], Venerino Poletti[SUP] 4 5 [/SUP], Simona di Cesare[SUP] 6 [/SUP], Elena Amicarelli[SUP] 6 [/SUP], Lucia Gardelli[SUP] 6 [/SUP], Carmela Grosso[SUP] 7 [/SUP], Aria Patacca[SUP] 7 [/SUP], Eleonora Magistrelli[SUP] 7 [/SUP], Michele De Benedetto[SUP] 8 [/SUP], Domenico Maurizio Toraldo[SUP] 9 [/SUP], Michele Arigliani[SUP] 8 [/SUP], Giovanni Cammaroto[SUP] 2 [/SUP], Giuseppe Meccariello[SUP] 2 [/SUP], Andrea De Vito[SUP] 10 [/SUP], Giuseppe Magliulo[SUP] 11 [/SUP], Antonio Greco[SUP] 11 [/SUP], Marco de Vincentiis[SUP] 11 [/SUP], Massimo Ralli[SUP] 11 [/SUP], Annalisa Pace[SUP] 11 [/SUP], Valentina Montincone[SUP] 12 [/SUP], Antonino Maniaci[SUP] 13 [/SUP], Salvatore Cocuzza[SUP] 13 [/SUP], Matteo Seligardi[SUP] 14 [/SUP], Ida di Giacinto[SUP] 15 [/SUP], Ruggero Massimo Corso[SUP] 16 [/SUP]



Affiliations

Abstract

Objectives: The purpose of this observational retrospective study was to evaluate, in patients with a severe acute respiratory syndrome coronavirus 2 infection, the association between the severity of coronavirus disease 2019 (COVID-19) respiratory illness and the risk of infected patients to develop obstructive sleep apnea (OSA).
Methods: Ninety-six patients with confirmed COVID-19 infection were enrolled in the study. The STOP-BANG questionnaire to investigate the risk of the OSA syndrome was filled in by the patients at admission. The enrolled patients were divided into 2 groups according to the respiratory disease: group 1 (72 patients), hospitalized patients undergoing conventional oxygen therapy; group 2 (24 patients), patients requiring enhanced respiratory support. STOP-BANG results of these 2 groups were compared to observe whether patients with high OSA risk more frequently presented a severe form of COVID-19.
Results: 41.6% of the patients in group 2 had a STOP-BANG score between 5 and 8 (high risk of having apnea); in contrast, 20.8% of the patients in group 1 had a STOP-BANG score between 5 and 8, with a statistically significant difference between the 2 groups (P = .05). A complementary trend was observed regarding the proportion of patients in the range 0 to 2, which classifies patients at a low risk of OSA (48.6% vs 20.8% for groups 1 and 2, P = .01).
Conclusions: According to our data, the chances of having a severe case of COVID-19 should be considered in patients at high risk of OSA.
Current knowledge/study rationale: Emerging research suggests that OSA could represent a potentially important risk factor for the severe forms of COVID-19. The purpose of this observational retrospective study was to evaluate the potential association between OSA and the severity of COVID-19 disease.
Study impact: According to our data, the likelihood of contracting a severe form of COVID-19 disease should be considered in patients at high risk of OSA.

Keywords: COVID-19; infection; obstructive sleep apnea; respiratory disease.
 
Back
Top Bottom